<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35664995</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2022</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2022.05.26.22275532</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2022.05.26.22275532</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">While much of the attention on the COVID-19 pandemic was directed at the daily counts of cases and those with serious disease overwhelming health services, increasingly, reports have appeared of people who experience debilitating symptoms after the initial infection. This is popularly known as long COVID.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To estimate by country and territory of the number of patients affected by long COVID in 2020 and 2021, the severity of their symptoms and expected pattern of recovery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">We jointly analyzed ten ongoing cohort studies in ten countries for the occurrence of three major symptom clusters of long COVID among representative COVID cases. The defining symptoms of the three clusters (fatigue, cognitive problems, and shortness of breath) are explicitly mentioned in the WHO clinical case definition. For incidence of long COVID, we adopted the minimum duration after infection of three months from the WHO case definition. We pooled data from the contributing studies, two large medical record databases in the United States, and findings from 44 published studies using a Bayesian meta-regression tool. We separately estimated occurrence and pattern of recovery in patients with milder acute infections and those hospitalized. We estimated the incidence and prevalence of long COVID globally and by country in 2020 and 2021 as well as the severity-weighted prevalence using disability weights from the Global Burden of Disease study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Analyses are based on detailed information for 1906 community infections and 10526 hospitalized patients from the ten collaborating cohorts, three of which included children. We added published data on 37262 community infections and 9540 hospitalized patients as well as ICD-coded medical record data concerning 1.3 million infections. Globally, in 2020 and 2021, 144.7 million (95% uncertainty interval [UI] 54.8-312.9) people suffered from any of the three symptom clusters of long COVID. This corresponds to 3.69% (1.38-7.96) of all infections. The fatigue, respiratory, and cognitive clusters occurred in 51.0% (16.9-92.4), 60.4% (18.9-89.1), and 35.4% (9.4-75.1) of long COVID cases, respectively. Those with milder acute COVID-19 cases had a quicker estimated recovery (median duration 3.99 months [IQR 3.84-4.20]) than those admitted for the acute infection (median duration 8.84 months [IQR 8.10-9.78]). At twelve months, 15.1% (10.3-21.1) continued to experience long COVID symptoms.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">The occurrence of debilitating ongoing symptoms of COVID-19 is common. Knowing how many people are affected, and for how long, is important to plan for rehabilitative services and support to return to social activities, places of learning, and the workplace when symptoms start to wane.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="UNASSIGNED"><b>Question:</b> What are the extent and nature of the most common long COVID symptoms by country in 2020 and 2021?<b>Findings:</b> Globally, 144.7 million people experienced one or more of three symptom clusters (fatigue; cognitive problems; and ongoing respiratory problems) of long COVID three months after infection, in 2020 and 2021. Most cases arose from milder infections. At 12 months after infection, 15.1% of these cases had not yet recovered.<b>Meaning:</b> The substantial number of people with long COVID are in need of rehabilitative care and support to transition back into the workplace or education when symptoms start to wane.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Sarah Wulf</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbafati</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Juridical and Economic Studies, La Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aerts</LastName><ForeName>Joachim G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Aly</LastName><ForeName>Ziyad</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>John T. Milliken Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Center, US Department of Veterans Affairs (VA), St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashbaugh</LastName><ForeName>Charlie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballouz</LastName><ForeName>Tala</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blyuss</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Population Health, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and Pediatric Infectious Diseases, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobkova</LastName><ForeName>Polina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Medicine (Pediatric profile), I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonsel</LastName><ForeName>Gouke</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>EuroQol Research Foundation, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borzakova</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pirogov Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Health Research Institute, Catholic University of Sacred Heart, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butnaru</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rose</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diab</LastName><ForeName>Mohamed Mustafa</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>The Center for Policy Impact in Global Health, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekbom</LastName><ForeName>Emil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Uppsala University Hospital, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Tantawi</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Dentistry and Dental Public Health Department, Alexandria University, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fomin</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Rector's Office, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frithiof</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamirova</LastName><ForeName>Aysylu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Medicine (General Medicine profile), I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glybochko</LastName><ForeName>Petr V</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Administration Department, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haagsma</LastName><ForeName>Juanita A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javanmard</LastName><ForeName>Shaghayegh Haghjooy</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Erin B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Gabrielle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Nursing, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heijenbrok-Kal</LastName><ForeName>Majanka H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurorehabilitation, Rijndam Rehabilitation, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helbok</LastName><ForeName>Raimund</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellemons</LastName><ForeName>Merel E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hillus</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; Medical University Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huijts</LastName><ForeName>Susanne M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hultstr&#xf6;m</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jassat</LastName><ForeName>Waasila</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Public Health Surveillance and Response, National Institute for Communicable Diseases, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurth</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; University Medical Center Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research and Tropical Medicine, Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Ing-Marie</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipcsey</LastName><ForeName>Mikl&#xf3;s</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chelsea</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loflin</LastName><ForeName>Callan D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>School of Nursing, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malinovschi</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Center for Policy Impact in Global Health, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Global Health Institute, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazankova</LastName><ForeName>Lyudmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Russian Medical Academy of Continuous Professional Education, Ministry of Healthcare of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCulloch</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menges</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology, Biostatistics and Prevention Institute, University of Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadifard</LastName><ForeName>Noushin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Heart &amp; Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nekliudov</LastName><ForeName>Nikita A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Clinical Medicine (General Medicine profile), I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogbuoji</LastName><ForeName>Osondu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Duke Global Health Institute, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osmanov</LastName><ForeName>Ismail M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>ZA Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pirogov Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;alvo</LastName><ForeName>Jos&#xe9; L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Maria Skaalum</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Occupational Medicine and Public Health, The Faroese Hospital System, Torshavn, Faroe Islands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Health Science, University of Faroe Islands, Torshavn, Faroe Islands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puhan</LastName><ForeName>Milo A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins University, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Mujibur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rass</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinig</LastName><ForeName>Nickolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribbers</LastName><ForeName>Gerard M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricchiuto</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>epartment of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubertsson</LastName><ForeName>Sten</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgical Sciences, Hedenstierna laboratory, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samitova</LastName><ForeName>Elmira</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ZA Bashlyaeva Children's Municipal Clinical Hospital, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Russian Medical Academy of Continuous Professional Education, Ministry of Healthcare of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarrafzadegan</LastName><ForeName>Nizal</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikhaleva</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Medicine (Pediatric profile), I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Kyle E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinatti</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soriano</LastName><ForeName>Joan B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>(Princess University Hospital), Autonomous University of Madrid, Hospital Universitario de La Princesa, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red Enfermedades Respiratorias (CIBERES), (Center for Biomedical Research in Respiratory Diseases Network), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiridonova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Medicine (General Medicine profile), I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbeis</LastName><ForeName>Fridolin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; Medical University Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svistunov</LastName><ForeName>Andrey A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Administration Department, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Water</LastName><ForeName>Brittney J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Global Health and Social Medicine, Harvard University, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nursing and Midwifery Department, Seed Global Health, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg-Emons</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallin</LastName><ForeName>Ewa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witzenrath</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; University Medical Center Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Lung Research, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hanzhang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Family Medicine and Community Health, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoller</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Respiratory Medicine, Charit&#xe9; Medical University Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adolph</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Political Science, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Statistics and the Social Sciences, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albright</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amlag</LastName><ForeName>Joanne O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aravkin</LastName><ForeName>Aleksandr Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Department of Applied Mathematics, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bang-Jensen</LastName><ForeName>Bree L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisignano</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellano</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakrabarti</LastName><ForeName>Suman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>James K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Xiaochen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daoud</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dapper</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deen</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Bruce B</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erickson</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewald</LastName><ForeName>Samuel B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Alize J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaxman</LastName><ForeName>Abraham D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fullman</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamkrelidze</LastName><ForeName>Amiran</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center for Disease Control and Public Health, Tbilisi, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giles</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Gaorui</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Simon I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jiawei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helak</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulland</LastName><ForeName>Erin N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kereselidze</LastName><ForeName>Maia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Center for Disease Control and Public Health, Tbilisi, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krohn</LastName><ForeName>Kris J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzar-Atwood</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindstrom</LastName><ForeName>Akiaja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Queensland Centre for Mental Health Research, Wacol, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magistro</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Munk School of Global Affairs and Public Policy, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malta</LastName><ForeName>Deborah Carvalho</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Maternal and Child Nursing and Public Health, Federal University of Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;nsson</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera</LastName><ForeName>Ana M Mantilla</ForeName><Initials>AMM</Initials><AffiliationInfo><Affiliation>West Moreton Hospital Health Services, Queensland Centre for Mental Health Research, Wacol, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mokdad</LastName><ForeName>Ali H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monasta</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology and Public Health Research Unit, Burlo Garofolo Institute for Maternal and Child Health, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomura</LastName><ForeName>Shuhei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Management, Keio University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health Policy, University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasovic</LastName><ForeName>Maja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pigott</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiner</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinke</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Antonio Luiz P</ForeName><Initials>ALP</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Telehealth, Federal University of Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santomauro</LastName><ForeName>Damian Francesco</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Policy and Epidemiology Group, Queensland Centre for Mental Health Research, Wacol, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sholokhov</LastName><ForeName>Aleksei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spurlock</LastName><ForeName>Emma Elizabeth</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale School of Public Health - Social and Behavioral Sciences, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walcott</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Evans School of Public Policy &amp; Governance, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Ally</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiysonge</LastName><ForeName>Charles Shey</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bettger</LastName><ForeName>Janet Prvu</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Christopher Jl</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vos</LastName><ForeName>Theo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 NR019019</GrantID><Acronym>NR</Acronym><Agency>NINR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG064303</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG061142</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 MD012530</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931</RefSource><PMID Version="1">36215063</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>6</Day><Hour>14</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35664995</ArticleId><ArticleId IdType="pmc">PMC9164454</ArticleId><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId><ArticleId IdType="pii">2022.05.26.22275532</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collins FS. NIH launches new initiative to study &#x201c;Long COVID.&#x201d; National Institutes of Health (NIH).
Published February 23, 2021. Accessed
June 7, 2021. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid</Citation></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, et al. Long-COVID: An evolving problem with an extensive impact. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 2020;111(1):10&#x2013;12. doi:10.7196/SAMJ.2020.v111i11.15433</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v111i11.15433</ArticleId><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Puhan M, Gao M, West E. Long COVID: Evolving Definitions, Burden of Disease and Socio-Economic Consequences. Swiss School of Public Health; 2021. Accessed
June 7, 2021. https://www.bag.admin.ch/bag/de/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/situation-schweiz-und-international/forschung-wissenschaft.html</Citation></Reference><Reference><Citation>Martimbianco ALC, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. n/a(n/a):e14357. doi:10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Accessed
November 5, 2021. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi:10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Advances in Understanding the Pathophysiology of Chronic Fatigue Syndrome. JAMA. 2019;322(6):499&#x2013;500. doi:10.1001/jama.2019.8312</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.8312</ArticleId><ArticleId IdType="pubmed">31276153</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi:10.1186/1471-2377-11-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. doi:10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front Med. 2021;7. doi:10.3389/fmed.2020.606824</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. COVID-19 and Your Health. Centers for Disease Control and Prevention.
Published February 11, 2020. Accessed
June 16, 2021. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi:10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi:10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021;199(2):113&#x2013;119. doi:10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Developing services for long COVID: lessons from a study of wounded healers. Clin Med. 2021;21(1):59&#x2013;65. doi:10.7861/clinmed.2020-0962</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0962</ArticleId><ArticleId IdType="pmc">PMC7850205</ArticleId><ArticleId IdType="pubmed">33479069</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G, Newcomb R, Cowl CT, et al. Post COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at the Mayo Clinic and Characteristics of the Initial Patient Cohort. Mayo Clin Proc. 2021;0(0). doi:10.1016/j.mayocp.2021.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open. 2021;4(5):e2111417. doi:10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Barrett KMS, Riffle S, et al. Long-term COVID-19 symptoms in a large unselected population. medRxiv. Published online December 1, 2020:2020.10.07.20208702. doi:10.1101/2020.10.07.20208702</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Coronavirus Infection Survey. Updated estimates of the prevalence of long COVID symptoms - Office for National Statistics. Published January 21, 2021. Accessed
February 2, 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/adhocs/12788updatedestimatesoftheprevalenceoflongcovidsymptoms</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi:10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto APA, Duarte LC, Cerqueira-Silva T, et al. Post-Acute COVID Syndrome, the Aftermath of Mild to Severe COVID-19 in Brazilian Patients. medRxiv. Published online June 9, 2021:2021.06.07.21258520. doi:10.1101/2021.06.07.21258520</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.07.21258520</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, Rahman MM, Rassel MA, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PloS One. 2021;16(4):e0249644. doi:10.1371/journal.pone.0249644</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLOS Med. 2016;13(6):e1002056. doi:10.1371/journal.pmed.1002056</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002056</ArticleId><ArticleId IdType="pmc">PMC4924581</ArticleId><ArticleId IdType="pubmed">27351744</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber RM, Sorensen RJD, Pigott DM, et al. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. The Lancet. 2022;0(0). doi:10.1016/S0140-6736(22)00484-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00484-6</ArticleId><ArticleId IdType="pmc">PMC8993157</ArticleId><ArticleId IdType="pubmed">35405084</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Paulson KR, Pease SA, et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020&#x2013;21. The Lancet. 2022;399(10334):1513&#x2013;1536. doi:10.1016/S0140-6736(21)02796-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Variation in the COVID-19 infection&#x2013;fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. The Lancet. 2022;399(10334):1469&#x2013;1488. doi:10.1016/S0140-6736(21)02867-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02867-1</ArticleId><ArticleId IdType="pmc">PMC8871594</ArticleId><ArticleId IdType="pubmed">35219376</ArticleId></ArticleIdList></Reference><Reference><Citation>Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection. Ann Intern Med. Published online June 3, 2020:M20&#x2013;3012. doi:10.7326/M20-3012</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3012</ArticleId><ArticleId IdType="pubmed">33587872</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712&#x2013;723. doi:10.1016/S2214-109X(15)00069-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(15)00069-8</ArticleId><ArticleId IdType="pubmed">26475018</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Cheng V, Manoharan L, et al.
Characterising long term Covid-19: a living systematic review | medRxiv. Accessed
August 24, 2021. https://www.medrxiv.org/content/10.1101/2020.12.08.20246025v2</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.08.20246025v2</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao W, Vos T, Wulf Hanson S, et al.
Long-term and short-term disease burden of COVID-19: a systematic review and meta-analysis. PROSPERO 2020 CRD42020210101. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=210101</Citation></Reference><Reference><Citation>ISRCTN Registry. Accessed
June 15, 2021. https://www.isrctn.com/</Citation></Reference><Reference><Citation>A global healthcare intelligence partner. PRA Health Sciences. Accessed
June 15, 2021. https://prahs.com/</Citation></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi:10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>VA research during the COVID-19 pandemic. Accessed
June 15, 2021. https://www.research.va.gov/covid-19.cfm</Citation></Reference><Reference><Citation>GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990&#x2013;2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Lond Engl. 2020;396(10258):1223&#x2013;1249. doi:10.1016/S0140-6736(20)30752-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30752-2</ArticleId><ArticleId IdType="pmc">PMC7566194</ArticleId><ArticleId IdType="pubmed">33069327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng P, Barber R, Sorensen RJD, Murray CJL, Aravkin AY. Trimmed Constrained Mixed Effects Models: Formulations and Algorithms. ArXiv190910700 Math Stat. Published online
October
27, Accessed
June 15, 2021. http://arxiv.org/abs/1909.10700</Citation></Reference><Reference><Citation>Puhan M, Fehr J, Abela I, et al.
Zurich SARS-CoV-2 Cohort: Towards a long-term control of SARS-CoV-2 transmission - Identifying the epidemiological, immunological and viral genetic drivers of SARS-CoV-2 transmission and pathogenesis in a representative population-based cohort. Accessed
June 11, 2021. https://www.isrctn.com/ISRCTN14990068</Citation></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis Off Publ Infect Dis Soc Am. Published online November 30, 2020:ciaa1792. doi:10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. Published online August 3, 2021:S2352&#x2013;4642(21)00198-X. doi:10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek LM, Berentschot JC, Hellemons ME, et al.
CO-FLOW: COvid-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: study protocol of a multicenter prospective cohort study following patients 2 years after hospital discharge. BMC Health Serv Res. 2021;21(1):847. https://www.trialregister.nl/trial/8710. doi:10.1186/s12913-021-06813-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-06813-6</ArticleId><ArticleId IdType="pmc">PMC8379596</ArticleId><ArticleId IdType="pubmed">34419032</ArticleId></ArticleIdList></Reference><Reference><Citation>ESRI Nederland. Coronavirus IC en verpleegafdeling-opnamen (Stichting NICE). Accessed
May 4, 2021. https://experience.arcgis.com/experience/e58fd5e1779b4cdd9d81e44b9b1032d0</Citation></Reference><Reference><Citation>Jun 14 P, 2021. State COVID-19 Data and Policy Actions. KFF.
Published June 14, 2021. Accessed
June 16, 2021. https://www.kff.org/coronavirus-covid-19/issue-brief/state-covid-19-data-and-policy-actions/</Citation></Reference><Reference><Citation>Ministerie van Volksgezondheid W en S. Besmette verpleeghuizen | Coronadashboard | Rijksoverheid.nl.
Accessed
June 16, 2021. https://coronadashboard.rijksoverheid.nl</Citation></Reference><Reference><Citation>De Federale overheidsdienst (FOD) Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu, Belgium. Coronavirus Covid-19. COVID-19 Weekly report.
Published June 11, 2021. Accessed
June 16, 2021. https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly_report_NL.pdf</Citation></Reference><Reference><Citation>Tableau de bord COVID-19. Tableau de bord COVID-19. Accessed
June 16, 2021. https://dashboard.covid19.data.gouv.fr</Citation></Reference><Reference><Citation>Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#x2013;2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204&#x2013;1222. doi:10.1016/S0140-6736(20)30925-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30925-9</ArticleId><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen RJD, Carter A, Welgan CA, et al. Variation in the COVID-19 infection-fatality rate by age, time and geography during the pre-vaccine era. Lancet.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8871594</ArticleId><ArticleId IdType="pubmed">35219376</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al. Preliminary evidence on long COVID in children. Acta Paediatr Oslo Nor 1992. 2021;110(7):2208&#x2013;2211. doi:10.1111/apa.15870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr Oslo Nor 1992. 2021;110(3):914&#x2013;921. doi:10.1111/apa.15673</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. medRxiv. Published online April 26, 2021:2021.04.26.21256110. doi:10.1101/2021.04.26.21256110</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.26.21256110</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Candan SA, Elibol N, Abdullahi A. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19. Physiother Theory Pract. 2020;36(6):663&#x2013;668. doi:10.1080/09593985.2020.1766181</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09593985.2020.1766181</ArticleId><ArticleId IdType="pubmed">32419564</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397(10270):220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Wong AW, Hague CJ, et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76(4):402&#x2013;404. doi:10.1136/thoraxjnl-2020-216308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Br&#xe4;uninger H, et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020;5(11):1281&#x2013;1285. doi:10.1001/jamacardio.2020.3551</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Golmai P, Larsen CP, DeVita MV, et al. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19. J Am Soc Nephrol JASN. 2020;31(9):1944&#x2013;1947. doi:10.1681/ASN.2020050683</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050683</ArticleId><ArticleId IdType="pmc">PMC7461690</ArticleId><ArticleId IdType="pubmed">32675304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Uppal NN, Wanchoo R, et al. COVID-19&#x2013;Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. J Am Soc Nephrol. 2020;31(9):1948&#x2013;1958. doi:10.1681/ASN.2020050699</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050699</ArticleId><ArticleId IdType="pmc">PMC7461689</ArticleId><ArticleId IdType="pubmed">32660970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameres M, Brandstetter S, Toncheva AA, et al. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. J Neurol. 2020;267(12):3476&#x2013;3478. doi:10.1007/s00415-020-10050-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10050-y</ArticleId><ArticleId IdType="pmc">PMC7345451</ArticleId><ArticleId IdType="pubmed">32647900</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, et al. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. MedRxiv Prepr Serv Health Sci. Published online March 5, 2021:2021.03.03.21252086. doi:10.1101/2021.03.03.21252086</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252086</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders&#x2019; conference. Crit Care Med. 2012;40(2):502&#x2013;509. doi:10.1097/CCM.0b013e318232da75</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232da75</ArticleId><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x201c;Just stay at home&#x201d; was lonely and terrifying | The BMJ. Accessed
June 9, 2021. https://www.bmj.com/content/371/bmj.m3807?ijkey=adc0934f8f53845e3c6ce83055645b4550903af4&amp;keytype2=tf_ipsecsha</Citation><ArticleIdList><ArticleId IdType="pubmed">33154066</ArticleId></ArticleIdList></Reference><Reference><Citation>COMET Initiative | Core Outcome Measures for Post-Covid condition/Long Covid. Accessed
August 24, 2021. https://www.comet-initiative.org/Studies/Details/1847</Citation></Reference><Reference><Citation>Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504&#x2013;1507. doi:10.1016/j.ajem.2020.04.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.04.048</ArticleId><ArticleId IdType="pmc">PMC7165109</ArticleId><ArticleId IdType="pubmed">32317203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032. doi:10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstr&#xf6;m M, Lipcsey M, Wallin E, Larsson IM, Larsson A, Frithiof R. Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care. 2021;25(1):37. doi:10.1186/s13054-021-03461-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03461-4</ArticleId><ArticleId IdType="pmc">PMC7829656</ArticleId><ArticleId IdType="pubmed">33494766</ArticleId></ArticleIdList></Reference><Reference><Citation>CNN TW. Clinics are springing up around the country for what some call a potential second pandemic: Long Covid. CNN. Accessed
June 29, 2021. https://www.cnn.com/2021/02/22/health/long-covid-clinics/index.html</Citation></Reference><Reference><Citation>CNN LSS
Jo Shelley and Livia Borghese. Brain fog, fatigue, breathlessness. Rehab centers set up across Europe to treat long-term effects of coronavirus. CNN. Accessed
June 29, 2021. https://www.cnn.com/2020/07/19/health/long-covid-italy-uk-gbr-intl/index.html</Citation></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, et al.
Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol. Published online
March
7, doi:10.1111/ene.14803. https://clinicaltrials.gov/ct2/show/NCT04416100</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrafzadegan N, Mohammadifard N, Haghjooy Javanmard S, et al. &#x201c;Isfahan COVID Cohort&#x201d; Study: Rationale, Methodology and Initial results. J Res Med Sci. Published online in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639724</ArticleId><ArticleId IdType="pubmed">36353352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurth F, Roennefarth M, Thibeault C, et al.
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020;48(4):619&#x2013;626. https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00021688. doi:10.1007/s15010-020-01464-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01464-x</ArticleId><ArticleId IdType="pmc">PMC7293426</ArticleId><ArticleId IdType="pubmed">32535877</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibeault C, M&#xfc;hlemann B, Helbig ET, et al. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. Published online April 22, 2021. doi:10.1007/s15010-021-01594-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01594-w</ArticleId><ArticleId IdType="pmc">PMC8061715</ArticleId><ArticleId IdType="pubmed">33890243</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultstr&#xf6;m M, Frithiof R, Lipcsey M. PRONMED Uppsala COVID-19 ICU Biobank. Published March 18, 2021.
https://clinicaltrials.gov/ct2/show/NCT04474249</Citation></Reference><Reference><Citation>Ekbom E, Frithiof R, &#xd6;I E, et al. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months postdischarge. Respir Med. 2021;182:106394. doi:10.1016/j.rmed.2021.106394</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106394</ArticleId><ArticleId IdType="pmc">PMC8047337</ArticleId><ArticleId IdType="pubmed">33901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et al. Asthma is associated with Long Covid in previously hospitalised adults: StopCOVID cohort study. Clinical and Experimental Allergy. Published online in review.</Citation></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open. 2021;4(2). doi:10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasio F, Barbuto S, Scarnecchia E, et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur Respir J. Published online January 1, 2021. doi:10.1183/13993003.04015-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04015-2020</ArticleId><ArticleId IdType="pmc">PMC7877327</ArticleId><ArticleId IdType="pubmed">33574080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S, Zahra H, Royer PY, et al. Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comt&#xe9; Hospital, France. Microorganisms. 2021;9(8):1719. doi:10.3390/microorganisms9081719</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081719</ArticleId><ArticleId IdType="pmc">PMC8401026</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. Published online December 3, 2020. doi:10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Nemati H, Shahisavandi M, et al. Long COVID in children and adolescents. World J Pediatr WJP. Published online September 3, 2021. doi:10.1007/s12519-021-00457-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker C, Beck K, Zumbrunn S, et al. Long COVID 1 year after hospitalisation for COVID-19: a prospective bicentric cohort study. Swiss Med Wkly. 2021;151:w30091. doi:10.4414/smw.2021.w30091</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2021.w30091</ArticleId><ArticleId IdType="pubmed">34694106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021;4(1):e2036142. doi:10.1001/jamanetworkopen.2020.36142</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg SK, Nielsen SD, Nygaard U, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022;6(4):240&#x2013;248. doi:10.1016/S2352-4642(22)00004-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27(2):258&#x2013;263. doi:10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N, Chowdhury M, Singh AK, et al. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther. 2021;15(3):156&#x2013;161. doi:10.5582/ddt.2021.01014</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01014</ArticleId><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021;174(4):576&#x2013;578. doi:10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B, et al. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open. 2021;11(8):e052838. doi:10.1136/bmjopen-2021-052838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052838</ArticleId><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo MDM, Foppiani A, Peretti GM, et al. Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort Study. Open Forum Infect Dis. 2021;8(8):ofab384. doi:10.1093/ofid/ofab384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab384</ArticleId><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group, Morin L, Savale L, et al. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021;325(15):1525&#x2013;1534. doi:10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Pawelek P, Bosworth M. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics. Published August 5, 2021. Accessed
August 24, 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/5august2021</Citation></Reference><Reference><Citation>Darcis G, Bouquegneau A, Maes N, et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2021;109:209&#x2013;216. doi:10.1016/j.ijid.2021.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.016</ArticleId><ArticleId IdType="pmc">PMC8278829</ArticleId><ArticleId IdType="pubmed">34273510</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M, Mudara C, Vika C, et al. LONG COVID IN SOUTH AFRICA: FINDINGS FROM A LONGITUDINAL COHORT OF PATIENTS AT ONE MONTH AFTER HOSPITALISATION WITH SARS-CoV-2, USING AN ISARIC MULTI-COUNTRY PROTOCOL. 19(0800):23.</Citation></Reference><Reference><Citation>Elkan M, Dvir A, Zaidenstein R, et al. Patient-Reported Outcome Measures After Hospitalization During the COVID-19 Pandemic: A Survey Among COVID-19 and Non-COVID-19 Patients. Int J Gen Med. 2021;14:4829&#x2013;4836. doi:10.2147/IJGM.S323316</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S323316</ArticleId><ArticleId IdType="pmc">PMC8405220</ArticleId><ArticleId IdType="pubmed">34471377</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, Padilla S, Fern&#xe1;ndez-Gonz&#xe1;lez M, et al. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study. J Clin Immunol. Published online July 17, 2021:1&#x2013;12. doi:10.1007/s10875-021-01083-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Postdischarge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. doi:10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022. doi:10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H, van der Hoeven JG, Corsten S, et al. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. JAMA. 2022;327(6):559&#x2013;565. doi:10.1001/jama.2022.0040</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.0040</ArticleId><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz LI, Garry K, Prete AM, et al. Six-Month Outcomes in Patients Hospitalized with Severe COVID-19. J Gen Intern Med. Published online August 5, 2021. doi:10.1007/s11606-021-07032-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07032-9</ArticleId><ArticleId IdType="pmc">PMC8341831</ArticleId><ArticleId IdType="pubmed">34355349</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, et al. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(3):e826&#x2013;e829. doi:10.1093/cid/ciab103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B, Eser F, Kalem AK, et al. Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. Published online July 13, 2021. doi:10.1002/jmv.27198</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27198</ArticleId><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H, Asseo K, Karni N, et al. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. Published online February 16, 2021:S1198&#x2013;743X(21)00083&#x2013;5. doi:10.1016/j.cmi.2021.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum TV, Aal&#xf8;kken TM, Br&#xf8;nstad E, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021;57(4):2003448. doi:10.1183/13993003.03448-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x201c;Long-COVID&#x201d;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. Published online November 10, 2020. doi:10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi:10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S, Haldar SN, Soneja M, et al. Post COVID-19 sequelae: A prospective observational study from Northern India. Drug Discov Ther. 2021;15(5):254&#x2013;260. doi:10.5582/ddt.2021.01093</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01093</ArticleId><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. Published online June 7, 2021:S1198&#x2013;743X(21)00281&#x2013;0. doi:10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, Crawford N, McNab S, Wurzel D, Steer A, Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22&#x2013;e23. doi:10.1016/S2352-4642(21)00124-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibila O, Albacar N, Perea L, et al. Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge. Arch Bronconeumol. 2021;57:59&#x2013;61. doi:10.1016/j.arbres.2021.01.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2021.01.036</ArticleId><ArticleId IdType="pmc">PMC7903150</ArticleId><ArticleId IdType="pubmed">34629656</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186. doi:10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A, Kalleberg KT, Dahl JA, et al. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PloS One. 2021;16(8):e0256142. doi:10.1371/journal.pone.0256142</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256142</ArticleId><ArticleId IdType="pmc">PMC8389372</ArticleId><ArticleId IdType="pubmed">34437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Robles M, Iguaran-Berm&#xfa;dez MDR, Garc&#xed;a-Klepizg JL, Lorenzo-Villalba N, M&#xe9;ndez-Bail&#xf3;n M. Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call check list. Pan Afr Med J. 2020;37:289. doi:10.11604/pamj.2020.37.289.27110</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2020.37.289.27110</ArticleId><ArticleId IdType="pmc">PMC7881918</ArticleId><ArticleId IdType="pubmed">33654513</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Cari&#xf1;ena A, Moreno E, et al. Post-COVID-19 functional status six-months after hospitalization. J Infect. 2021;82(4):e31&#x2013;e33. doi:10.1016/j.jinf.2020.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Saddik B, AlSwaidan N, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PloS One. 2021;16(12):e0260568. doi:10.1371/journal.pone.0260568</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260568</ArticleId><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021;149:e32. doi:10.1017/S0950268821000145</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga V, Chevinsky JR, Dimitrov LV, et al. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1235&#x2013;1241. doi:10.15585/mmwr.mm7036a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7036a1</ArticleId><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27(1):89&#x2013;95. doi:10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>